https://european-biotechnology.net/wp-content/uploads/2026/03/Team-picture-2-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-09 08:00:022026-03-09 08:00:02kyron.bio teams up with Servier to test “precision glycosylation” as a new lever for antibody performance
https://european-biotechnology.net/wp-content/uploads/2026/03/darpin-radio-image-web.png540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-06 07:11:162026-03-09 16:32:03Radioligands give Molecular Partners new momentum in a market already at full speed
https://european-biotechnology.net/wp-content/uploads/2026/03/amol-tyagi-zyJyB9S1oZs-unsplash-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-04 08:45:512026-03-04 08:45:51Boehringer steps back from MASH programm as OSE restructure its pipeline
https://european-biotechnology.net/wp-content/uploads/2026/03/nvision-PHIP-Nagel-Luca-TUM.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-03 07:34:012026-03-03 07:34:01NVision visualizes metabolics at work and expands to the Cambridge Innovation Cluster
https://european-biotechnology.net/wp-content/uploads/2026/02/Sitryx-Lab-1_web960540.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-27 10:45:162026-02-27 10:45:16Sitryx adds another BigPharma and partners with Boehringer Ingelheim in autoimmune push
https://european-biotechnology.net/wp-content/uploads/2026/02/2018_09_20_novonordisk.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-26 09:29:032026-02-26 09:29:03Novo Nordisk partners with MIT spinout Vivtex in deal worth up to $2.1bn to advance oral biologics for obesity
